Trisubstituted purine derivatives
US8592581B2 · kind B2 · utility
4Cited by
4References
32Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 5, 2009 |
| Grant date | Nov 26, 2013 |
| Priority date | — |
| Expiry date | May 17, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula (I)wherein: where one of X, Y and Z is N and the remainder are CR9; A further aspect of the invention relates to pharmaceutical compositions comprising compounds of formula (I), and the use of said compounds in treating proliferative disorders, viral disorders, stroke, alopecia, CNS disorders, neurodegenerative disorders, or diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.